Keynote lectures
|
Thursday, 10 October 2019
|
|
13:15-13:45
|
|
Jürgen Hescheler
Director, Institute for Neurophysiology, University of Cologne, DE-Cologne
Update on human stem cells - scientific, ethical and legal challenges
|
Friday, 11 October 2019
|
|
09:00-09:30
|
|
Susanna Louhimies
Policy coordinator at the European Commission, BE-Brussels
Implementing Directive 2010/63/EU - current status and next steps
|
Saturday, 12 October 2019
|
|
09:00-09:30
|
|
Christoph Giese, DE-Berlin
Director QC and CATS at ProBioGen AG, DE-Berlin
Human Artificial Lymph Node Model (HuALN) for biopharmaceutical testing and disease modelling in vitro
|
Sunday, 13 October 2019
|
|
09:00-09:30
|
|
Mihael H. Polymeropoulos, US-Washington DC
President and CEO, Vanda Pharmaceuticals Inc., US-Washington DC
Challenging FDA’s requirement for long term studies in dogs for the safety assessment of drugs and pharmaceuticals
|
